尼古丁会影响平滑肌肉的cAMP信号和血管反应
Navid Singhrao1, Victor A Flores-Tamez1, Yumna A Moustafa1
1Department of Pharmacology, University of California, Davis, California, USA.
概括
尼古丁暴露会减少血管光滑肌 (VSM) 中的循环腺单酸盐 (cAMP) 生产,损害血管放松. 这种与尼古丁产品相关的效应可能会导致血管并发症.
科学领域:
- 心血管生物学 心血管生物学
- 药理学 药理学是指药理学的学科.
- 分子信号传输的方法
背景情况:
- 尼古丁是烟草制品的主要成分,已知会影响心血管健康.
- 血管光滑肌 (VSM) 在调节血压和血管度方面发挥着至关重要的作用.
- 循环腺单酸盐 (cAMP) 是一个关键的第二信使,参与VSM放松和β-上腺体信号传递.
研究的目的:
- 研究尼古丁对VSM中受体介导cAMP合成的影响.
- 为了确定尼古丁是否会损害VSM中的β-上腺素介导的cAMP信号.
- 了解尼古丁如何通过对cAMP信号的改变影响血管反应.
主要方法:
- 利用从小鼠中获得的VSM细胞和急性隔离的大动脉,这些细胞被设计成表达cAMP传感器TEpacVV (Camper),特别是在VSM (CamperSM).
- 评估因尼古丁暴露和二手烟 (SHS) 引起的异二醇 (ISO) 诱导的cAMP产生.
- 评估了对ISO诱导的血管扩张的功能后果以及固醇酶3 (PDE3) 抑制的作用.
主要成果:
- 尼古丁显著降低了VSM细胞和动脉中ISO诱导的cAMP产生,使用CamperSM小鼠证实了这一点.
- 尼古丁损害的cAMP信号阻碍了ISO诱导的血管扩张.
- 与PDE3抑制剂同时使用可逆转尼古丁诱导的血管扩张障碍.
结论:
- 尼古丁破坏了VSM中β-上腺素介导的cAMP信号传递.
- 这些cAMP信号的变化导致血管扩张受损,并可能导致血管并发症.
- 这些发现突出了将尼古丁使用与心血管疾病风险联系起来的潜在机制.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Cholinergic Receptors: Nicotinic
2.6K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.6K
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Parasympathetic Signaling
1.9K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
1.9K
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K


